U.S. market Closed. Opens in 1 day 6 hours 1 minute

COCP | Cocrystal Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
RevenueN/AN/AN/A2.01M6.56MN/AN/AN/A78.00K9.00KN/A17.19M12.61MN/AN/AN/AN/A
Cost of Revenue15.17M241.60K239.50K238.90K4.00K50.00K101.00K201.00K192.00K4.07K3.86K9.97M8.64M3.80K4.60K1.80K1.80K
Gross Profit-15.17M-241.60K-239.50K1.78M6.56M-50.00K-101.00K-201.00K-114.00K4.93K-3.86K7.22M3.97M-3.80K-4.60K-1.80K-1.80K
Operating Expenses3.39M18.14M14.22M11.60M8.87M62.92M8.26M105.82M54.03M5.81M3.30M9.86M7.85M49.49K42.85K55.85K61.52K
Selling, General & Admin5.99M5.75M5.43M5.29M4.86M4.35M2.44M4.14M6.76M1.74M3.28M7.12M7.45M49.49K42.85K55.85K61.52K
Research & Development15.17M12.39M8.79M6.31M4.00M58.57M5.82M101.68M47.26M4.07M17.50K743.09K399.62KN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/A-131.00K-1.00K-1.69M-591.00K3.28M2.00M7.45MN/A1.44K2.94K61.52K
Operating Income-18.56M-38.83M-14.22M-9.59M-48.41M-62.92M-8.26M-105.82M-53.95M-5.80M-3.30M-2.64M-3.89M-49.49K-42.85K-55.85K-61.52K
Other Expenses / Income575.00K-8.00K36.00K-62.00K237.00K294.00K769.00K1.55M-11.42M5.65M-8.34M-5.33M-1.57M1.01K244.002.94K2.80K
Before Tax Income-17.98M-38.84M-14.19M-9.65M-48.17M-62.63M-7.49M-104.27M-65.37M-151.00K-11.64M-7.96M-5.45M-48.48K-41.37K-52.92K-58.72K
Income Tax ExpensesN/A8.00K4.00K8.00K19.00K-13.58M-6.88M-29.39M-15.25M-52.00K12.12M5.48M3.27K-1.01K-1.48K-2.94K-700.00
Net Income-17.98M-38.84M-14.19M-9.66M-48.19M-49.05M-613.00K-74.87M-50.12M-99.00K-19.62M-7.96M-5.46M-48.48K-41.37K-52.92K-58.72K
Interest ExpensesN/A2.00K4.00K8.00K19.00KN/AN/AN/AN/AN/A3.34M5.48M1.24M439.02KN/AN/AN/A
Basic Shares Outstanding9.65K8.14M88.37M55.22M31.86M2.33M2.01M1.96M1.75M340.26K316.49K175.40K153.28K124.30K104.72K104.72K95.23K
Diluted Shares Outstanding9.65K8.14M88.37M55.22M31.86M2.33M2.01M1.96M1.75M340.26K316.49K175.40K153.28K124.30K104.72K104.72K95.23K
EBITDA-19.37M-38.45M-13.80M-9.30M-47.90M-62.52M-7.39M-105.62M-53.76M-5.60M-3.85M-2.64M-3.68M-49.08K-42.27K-53.30K-61.52K
EBITDA Margin0.00%0.00%0.00%-461.97%-729.68%0.00%0.00%0.00%-68,917.95%-62,222.22%0.00%-15.34%-29.19%0.00%0.00%0.00%0.00%
EBIT-17.98M-38.84M-14.18M-9.64M-48.15M-62.63M-7.49M-104.27M-65.37M-151.00K-4.16M3.00M-4.21M389.52K-42.85K-55.85K-59.42K
EBIT Margin0.00%0.00%0.00%-478.65%-733.55%0.00%0.00%0.00%-83,807.69%-1,677.78%0.00%17.44%-33.41%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙